1. Home

Program

Filter activities
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
13:00 - 14:30
IODINE GLOBAL NETWORK IODINE GLOBAL NETWORK

Session I

13:00 - 13:10
Introduction
13:10 - 13:30
Despite major progress, iodine deficiency remains a global health problem in 2025
13:30 - 13:45
The history of the elimination of iodine deficiency disorders in the Americas
13:45 - 14:00
Awareness and capacity building to sustain optimal iodine nutrition in Latin America
14:00 - 14:15
Effects of iodine intake on thyroid autoimmunity
14:15 - 14:30
Iodotyrosines as novel biomarkers for iodine deficiency
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
14:30 - 16:30
IODINE GLOBAL NETWORK IODINE GLOBAL NETWORK

Break

Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
16:30 - 18:00
IODINE GLOBAL NETWORK IODINE GLOBAL NETWORK

Session II

16:30 - 16:45
Strengthening design and surveillance of salt iodization to support safe and effective programs on thyroid function
16:45 - 17:00
Not too little, not too much: the Chilean iodine fortification experience
17:00 - 17:15
Iodine nutritional status in Brazil
17:15 - 17:30
Iodine supplementation in pregnancy in Brazil
17:30 - 17:45
The Danish investigation on iodine intake and thyroid disease (DanThyr): history and implications
17:45 - 18:00
Iodine status in Colombia and its possible association with thyroid autoimmunity
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
08:00 - 08:10
KOCHER CONFERENCE KOCHER CONFERENCE

Opening

Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
08:10 - 09:30
KOCHER CONFERENCE KOCHER CONFERENCE

First Session

08:10 - 08:30
Navigating uncertainly: advancements in managing indeterminate thyroid nodules
08:30 - 08:45
RFA x MW – Nuances of indications and techniques
08:45 - 09:00
Is thermal ablation safe for malignancies?
09:00 - 09:15
Expanding the indications for thermal ablations
09:15 - 09:30
Q&A
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
09:30 - 10:30
KOCHER CONFERENCE KOCHER CONFERENCE

Second Session

09:30 - 09:50
Effective surveillance strategies for micropapillary thyroid cancer: integrating surgical insight
09:50 - 10:05
Total thyroidectomy x Lobectomy (indications and follow-up
10:05 - 10:20
Defining the best preoperative apporoach for thyroid cancer
10:20 - 10:30
Q&A
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
10:30 - 10:45
KOCHER CONFERENCE KOCHER CONFERENCE

Break

Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
10:45 - 11:30
KOCHER CONFERENCE KOCHER CONFERENCE

Third Session

10:45 - 11:00
Medical management of GD: When is the time for RAI?
11:00 - 11:15
Way and when Surgery for GD
11:15 - 11:30
Q&A
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
11:30 - 12:15
KOCHER CONFERENCE KOCHER CONFERENCE

Fourth Session

11:30 - 11:45
Autofluorescence and Parathyroid Vascular Assessment
11:45 - 12:00
Remote thyroid access: breakthroughs and future directions in surgical innovation
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
12:15 - 12:30
KOCHER CONFERENCE KOCHER CONFERENCE

Presentation of the New Book "Carcinoma Diferenciado de Tiroides de Bajo Riesgo"

Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
12:30 - 13:00
KOCHER CONFERENCE KOCHER CONFERENCE

Keynote lecture: Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and poto-operartive findings

Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
13:00 - 14:00
KOCHER CONFERENCE KOCHER CONFERENCE

Fifth Session

13:00 - 13:15
Poorly Differentiated Thyroid Cancer – Contemporary Definitions and Management
13:15 - 13:30
Neoadjuvant Therapy for Advanced Disease
13:30 - 13:45
Disparities in Access to Thyroid Care
13:45 - 14:00
Q&A
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
14:00 - 15:45
KOCHER CONFERENCE KOCHER CONFERENCE

Interdisciplinary tumor board: collaborative strategies for thyroid cancer management

Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
15:45 - 16:00
KOCHER CONFERENCE KOCHER CONFERENCE

Closing remarks

Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
08:00 - 10:00
ULTRASOUND COURSE ULTRASOUND COURSE

Session 1

08:00 - 08:10
Introduction
08:10 - 08:40
Basic Principles of Thyroid Ultrasound and Device Settings to Optimize Imaging
08:40 - 09:10
Ultrasound of Diffuse Thyroid Disorders
09:10 - 09:40
Challenges in Thyroid Nodule Imaging
09:40 - 10:00
Assessment of Cervical Lymph Nodes
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
10:00 - 10:30
ULTRASOUND COURSE ULTRASOUND COURSE

Break

Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
10:30 - 11:50
ULTRASOUND COURSE ULTRASOUND COURSE

Session 2

10:30 - 10:50
Artificial Intelligence for Evaluation of Thyroid Nodules
10:50 - 11:10
Parathyroid Imaging
11:10 - 11:30
Nonthyroid neck pathology
11:30 - 11:50
Techniques to Optimize Fine Needle Aspiration Biopsy
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
11:50 - 13:00
ULTRASOUND COURSE ULTRASOUND COURSE

Break

Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
13:00 - 16:00
ULTRASOUND COURSE ULTRASOUND COURSE

Session 3

13:00 - 13:20
Correlation between ultrasound and thyroid cytology
13:20 - 13:40
Patient demos - Examining phisician
13:40 - 16:00
Presentation of clinical cases

* Sponsored activities and lectures (such as Satellite Symposia) are conducted under the responsibility of the sponsoring company and follow its respective compliance rules. In addition to these rules, certain measures are also adopted, such as granting exclusive access to prescribers during the satellite symposia, in order to fully comply with ANVISA’s regulations, particularly those set forth in RDC nº. 96/2008. These restrictions will be disclosed in the scientific program.

Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
11:00 - 13:00
LEGACY LUNCH -

Insights, Challenges, and Reflections from Leaders of Thyroid Research (Restricted Session – Attendance by prior confirmation only)

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
15:00 - 16:10
TUMOR BOARD THYROID CANCER

Tumor Board in the context of the new guidelines

Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
15:00 - 16:20
SYMPOSIUM PEDIATRICS & GENETIC DISEASES

Updates on neonatal CH screening

15:00 - 15:20
Metabolomics can be of help?
15:20 - 15:40
Is neonatal diagnosis of Central Hypothyroidism worthy to be implemented?
15:40 - 16:00
The changing spectrum of CH after the loweing of TSH thresholds
16:00 - 16:20
Discussion
Room 3 – Marcos S. Abalovich (LATS President 2011-2013; Argentina)
15:00 - 15:50
MEET THE PROFESSOR GOITER, IODINE AND OTHER ENVIRONMENTAL FACTORS

Environmental endocrine disruptors

15:00 - 15:30
Animal Models
15:30 - 15:50
Discussion
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
15:00 - 16:20
SYMPOSIUM AUTOIMMUNITY

Advances in role of TSHR

15:00 - 15:20
Advances in structural biology
15:20 - 15:40
TSHR-IGF1R crosstalk
15:40 - 16:00
Utility of TSHR antibodies in clinical practice-Graves'
16:00 - 16:20
Discussion
Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
15:00 - 16:20
SYMPOSIUM REGULATION OF TH M&S

Thyroid hormone action in health and disease

15:00 - 15:20
Structure and function of type 2 and type 3 deiodinase enzymes
15:20 - 15:40
Thyroid hormone in non-alcohholic liver diseases
15:40 - 16:00
Thyroid hormone and muscle differentiation
16:00 - 16:20
Discussion
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
16:20 - 17:20
HOT ABSTRACTS ABSTRACTS

Hot Abstracts - Clinical

16:20 - 16:35
1112237 - REAL-WORLD EXPERIENCE WITH LENVATINIB PLUS PEMBROLIZUMAB IN METASTATIC BRAF WILD-TYPE ANAPLASTIC THYROID CARCINOMA (BRAFWT-ATC) | Presenter: SARAH HAMIDI
16:35 - 16:50
1112402 - REDIFFERENTIATION OF REFRACTORY THYROID CANCER OF FOLLICULAR ORIGIN: NATIONAL FRENCH REAL LIFE EXPERIENCE | Presenter: LAMARTINA
16:50 - 17:05
1112371 - T3 ANALOGUE TRIIODOTHYROACETIC ACID (TRIAC) TREATMENT AND SURVIVAL IN MCT8 DEFICIENCY: AN INTERNATIONAL REAL-WORLD COHORT STUDY | Presenter: FLOOR VAN DER MOST
17:05 - 17:20
1112577 - TOTAL TRIIODOTHYRONINE AND TOTAL THYROXINE LEVELS ARE POSITIVELY ASSOCIATED WITH PREGNANCY LOSS OF CHROMOSOME NORMAL (EUPLOID) FETUSES | Presenter: SOFIE BLIDDAL
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
16:20 - 17:20
HOT ABSTRACTS ABSTRACTS

Hot Abstracts - Basic

16:20 - 16:35
1112267 - CHARACTERIZATION OF PATIENT DERIVED XENOGRAFTS (PDX) MOUSE MODELS AND THEIR RESPECTIVE CELL LINES FROM ANAPLASTIC THYROID CANCER (ATC) | PRESENTER : MIRA SALEH
16:35 - 16:50
1112491 - ENDOCRINE DISRUPTORS MIXTURE IMPAIRS THYROID DIFFERENTIATION THROUGH EPIGENETIC MECHANISMS AND DYSREGULATED PKA AND AKT SIGNALING PATHWAYS | PRESENTER: GUILHERME HENRIQUE
16:50 - 17:05
1112483 - IMPACT OF MICROBIOTA-NLRP3 INFLAMMASOME INTERACTIONS ON PROGRESSION OF AUTOIMMUNE THYROIDITIS | PRESENTER: BOSHEN GONG
17:05 - 17:20
1112666 - REGULATION OF ADULT NEUROGLIOGENESIS BY DIO2 IN MOUSE BRAIN: A TALE OF TWO WAVES | PRESENTER: VICTOR VALCARCEL HERNÁNDEZ
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
16:20 - 17:20
HOT ABSTRACTS ABSTRACTS

Hot Abstracts - Translational

16:20 - 16:35
1112615 - MECHANISMS IN THYROID EYE DISEASE (TED) - TSH RECEPTOR ANTIBODIES ENHANCE THE EXPRESSION OF BOTH TSH RECEPTORS AND IGF-1 RECEPTORS IN FIBROBLASTS. | PRESENTER: TERRY FRANCIS DAVIES
16:35 - 16:50
1112290- PD-L1 ACTIVATES INTRINSIC CELLULAR FUNCTIONS IN THYROID CELLS: IMPLICATIONS FOR IMMUNE CHECKPOINT INHIBITOR INDUCED THYROIDITIS | PRESENTER: MIHAELA STEFAN LIFSHITZ
16:50 - 17:05
1112488 - ROLE OF T3 IN DENDRITIC CELL ACTIVATION: INSIGHTS INTO THE METABOLIC REPROGRAMMING AND ITS FUNCTIONAL IMPACT | PRESENTER: ANTONELLA BLANCO
17:05 - 17:20
1112247 - THE ROLE OF TYPE 3 DEIODINASE IN A HUMAN MODEL FOR EARLY BRAIN DEVELOPMENT | PRESENTER: ANNA LOPEZ MARTI
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
17:30 - 19:50
OPENING CEREMONY OPENING CEREMONY

ITC Opening Ceremony - 17th International Thyroid Congress

17:30 - 17:40
Speech - LATS President
17:40 - 17:45
Speech - Presidents of ETA, AOTA, and ATA
17:45 - 17:50
Speech - Thyroid Federation International
17:50 - 18:00
Speech - LOC President
18:00 - 18:10
Speech - POC President
18:10 - 18:35
Advances in thyroid cancer management (LATS)
18:35 - 19:00
What has changed in Thyroid Eye Disease? (ETA)
19:00 - 19:25
Surgical approach changes in thyroid cancer over the years (ATA)
19:25 - 19:50
Progress in Basic thyroid research: a 5 year overview (AOTA)

* Sponsored activities and lectures (such as Satellite Symposia) are conducted under the responsibility of the sponsoring company and follow its respective compliance rules. In addition to these rules, certain measures are also adopted, such as granting exclusive access to prescribers during the satellite symposia, in order to fully comply with ANVISA’s regulations, particularly those set forth in RDC nº. 96/2008. These restrictions will be disclosed in the scientific program.

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
07:00 - 08:25
EARLY RISER SYMPOSIA THYROID CANCER

Thyroid cancer management: Difficult clinical cases

07:00 - 08:25
Representative for ATA
07:00 - 08:25
Representative for AOTA
07:00 - 08:25
Representative for ETA
07:00 - 08:25
Representative for LATS
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
08:30 - 09:00
PLENARY PLENARY SESSION

30 years of active surveillance for low risk thyroid cancer, lessons learned and future directions

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
09:00 - 09:30
PLENARY PLENARY SESSION

Thyroid hormone analogues and potential applications

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
09:30 - 09:45
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
09:45 - 10:30
LATS PRIZE LECTURE -

LATS PRIZE LECTURE

09:45 - 10:30
My Journey in Thyroid Research
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
10:35 - 12:00
DEBATE THYROID & PREGNANCY

TSH threshold for replacement thyroid hormone in pregnancy

10:35 - 10:55
For the proposal
10:55 - 11:15
Against for the proposal
11:15 - 12:00
Discussion
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
10:35 - 12:00
DEBATE AUTOIMMUNITY

Is Surgical Treatment Still an Option for Thyroid Eye Disease?

10:35 - 10:55
For the proposal
10:55 - 11:15
Against the proposal
11:15 - 12:00
Discussion
Room 3 – Marcos S. Abalovich (LATS President 2011-2013; Argentina)
10:35 - 11:30
MEET THE PROFESSOR GOITER, IODINE AND OTHER ENVIRONMENTAL FACTORS

Iodine and nutrition: Global Trends

10:35 - 10:55
Global iodine nutrition and thyroid diseases: Where do we stand in 2025?
10:55 - 11:15
State-of-the-Art Guidelines for Monitoring Iodine Nutrition in Populations
11:15 - 11:30
Discussion
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
10:35 - 11:30
MEET THE PROFESSOR REGULATION OF TH M&S

Thyroid hormone and disease mechanisms

10:35 - 10:55
MCT8 thyroid hormone transporter and disease
10:55 - 11:15
The Leptin-D2 axis controls the energy balance in Skeletal muscle
11:15 - 11:30
Discussion
Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
10:35 - 11:30
MEET THE PROFESSOR PEDIATRICS & GENETIC DISEASES

Pediatric thyroid cancer: Recent advances

11:15 - 11:30
Discussion
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
10:35 - 11:30
MEET THE PROFESSOR THYROID CANCER

Role of calcitonin measurement in the surgical decision making

11:15 - 11:30
Discussion
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
10:35 - 11:30
MEET THE PROFESSOR THYROID NODULES

The ATA approach of molecular testing for thyroid nodules

11:15 - 11:30
Discussion
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
11:30 - 14:45
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
11:30 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
13:00 - 14:00
SHORT ORAL COMMUNICATIONS ABSTRACTS

SHORT ORAL COMMUNICATIONS - Clinical and Translational Thyroid Cancer

13:00 - 13:05
1112409 - PREDICTIVE FACTORS OF RADIOACTIVE IODINE-REFRACTORY EVOLUTION OF THYROID CANCER IN A PROSPECTIVE COHORT | Presenter:LAURINE MEBARKI
13:05 - 13:10
1112342 - IMPACT OF PHYSICAL ACTIVITY AND ITS MAINTENANCE IN THE EFFICACY AND SAFETY OF TYROSINE KINASE INHIBITORS IN ADVANCED THYROID CARCINOMA PATIENTS | Presenter: CARLA COLOMBO
13:10 - 13:15
1112385 - LESIONAL DOSIMETRY IN 131I REFRACTORY METASTATIC DIFFERENTIATED THYROID CANCER WITH BRAFP.V600E OR RAS MUTATION TREATED WITH TRAMETINIB +/- DABRAFENIB FOLLOWED BY HIGH ACTIVITY OF RADIOACTIVE IODINE | Presenter: SOPHIE LEBOULLEUX
13:15 - 13:20
1112183 - LONG-TERM OUTCOME FOR PAPILLARY THYROID CARCINOMA WITH LUNG METASTASIS | Presenter: IWAO SUGITANI
13:20 - 13:25
1112956 - Exposomic Analysis of Thyroid Cancer: Correlating histopathological characteristics with persistent environmental organic pollutants | Presenter: THOMAS SZABO YAMASHITA
13:25 - 13:30
1112631 - ANALYTICAL VALIDATION OF A CUSTOMIZED TARGETED RNA NGS PANEL FOR DETECTING GENETIC ALTERATIONS IN 57 RECURRENT MUTATED GENES FOR DIAGNOSIS AND PROGNOSIS OF INDETERMINATE THYROID NODULES AND THYROID CANCER | Presenter: ISABELA NOGUEIRA NUNES
13:30 - 13:35
1112329 - ASSESSMENT OF INTERNATIONAL MEDULLARY THYROID CARCINOMA GRADING SYSTEM PROGNOSIS IN PATIENTS WITH DISTANT METASTASES.| Presenter: TOMMASO PORCELLI
13:35 - 13:40
1112623 - CHALLENGES IN DETERMINING THE OPTIMAL TIMING FOR THYROID REMOVAL IN YOUNG MEN2A PATIENTS: INSIGHTS FROM TWO BRAZILIAN REFERRAL CENTERS | Presenter: LAURA MARMITT
13:40 - 13:45
1112460 - CIRCULATING MICRORNAS IN THE FOLLOW-UP OF PATIENTS WITH PAPILLARY THYROID CARCINOMA | Presenter: NATHÁLIA DA CRUZ DE SOUSA MURAD
13:45 - 13:50
1113636 - ALK Inhibition Prolongs Survival in a Mouse Model of ALK-positive Anaplastic Thyroid Cancer | Presenter: YARA MARIA MACHLAH
13:50 - 13:55
1112228 - IMMUNOMODULATORY EFFECTS OF LENVATINIB IN ADVANCED THYROID CARCINOMA | Presenter: PRASHANT CHANGOER
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
13:00 - 14:00
SHORT ORAL COMMUNICATIONS ABSTRACTS

SHORT ORAL COMMUNICATIONS - Thyroid Nodules and Surgery

13:00 - 13:05
1112644 - DEFINING A CUTOFF FOR CALCITONIN LEVELS IN FINE-NEEDLE ASPIRATION WASHOUT FLUID TO EXCLUDE MEDULLARY THYROID CARCINOMA DIAGNOSIS | Presenter:GUSTAVO IVANI DE PAULA
13:05 - 13:10
1112476 - REVOLUTIONIZING BENIGN NODULE TREATMENT: THE IMPACT OF RADIOFRECUENCY ABLATION| Presenter: JORGELINA L. GUERRA
13:10 - 13:15
1112527 - TRANSFORMING PARATHYROID SURGERY: THE ROLE OF RADIOFREQUENCY ABLATION IN TREATING ADENOMAS | Presenter: ANA INES VOOGD
13:15 - 13:20
1112390 - ENHANCED ALGORITHM FOR THYROID NODULE CLASSIFICATION: PERFORMANCE COMPARISON OF MIR-THYPE V1 AND V2 | Presenter: MARCOS TADEU DOS SANTOS
13:20 - 13:25
1112275 - RADIOFREQUENCY ABLATION VERSUS ETHANOL ABLATION FOR BENIGN THYROID NODULES TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS | Presenter: ALINE LEVY SITNOVETER
13:25 - 13:30
1112455 - REDEFINING BETHESDA III: THE VALUE OF BINARY STRATIFICATION IN PREDICTING THYROID MALIGNANCY | Presenter:VERONICA ILERA
13:30 - 13:35
1112599 - ULTRASONOGRAPHIC-HISTOLOGICAL CORRELATION OF THYROID NODULES IN A CHILEAN CENTER AND PERFORMANCE OF ACR-TIRADS VARIABLES | Presenter: NICOLE LUSTIG FRANCO
13:35 - 13:40
1112186 - IDENTIFYING PREDICTORS OF PERMANENT HYPOPARATHYROIDISM AFTER THYROID CANCER SURGERY—A COMPREHENSIVE REAL-LIFE RETROSPECTIVE ANALYSIS | Presenter: ROSSELLA MELCARNE
13:40 - 13:45
1112242 - INTRAOPERATIVE USE OF FLUORESCENCE WITH INDOCYANINE GREEN TO PREDICT POSTOPERATIVE HYPOPARATHYROIDISM.| Presenter: RASMUS REINKE
13:45 - 13:50
1112305 - LARYNGEAL ULTRASOUND PERFORMANCE FOR THE DIAGNOSIS OF VOCAL CORD PARALYSIS POST-THYROIDECTOMY: A MULTICENTER DIAGNOSTIC TEST STUDY IN MEDELLIN, COLOMBIA. | Presenter:DAVID MAURICIO FIGUEROA BOHORQUEZ
13:50 - 13:55
1112391 - PREOPERATIVE MIR-146B EXPRESSION AS A PREDICTOR OF AGGRESSIVE OUTCOMES IN DIFFERENTIATED THYROID CARCINOMAS | Presenter: MARCOS TADEU DOS SANTOS
Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
13:00 - 14:00
SHORT ORAL COMMUNICATIONS ABSTRACTS

SHORT ORAL COMMUNICATIONS - Thyroid Cancer Basic

13:00 - 13:05
1112395 - DELIVERY OF MIR-485-5P AND MIR-495-3P VIA EXTRACELLULAR VESICLES IMPAIRS CELL MIGRATION AND INVASION IN THYROID CANCER CELLS | Presenter: MURILO VIEIRA GERALDO
13:05 - 13:10
1112387 - IN VIVO DETECTION OF THE MOLECULAR MECHANISMS OF CELL DEATH INDUCED BY CARBON ION THERAPY IN ANAPLASTIC THYROID CANCER | Presenter: PIETRO DI FAZIO
13:10 - 13:15
1112367 - METFOMIN REDUCES JAK/STAT PATHWAY ACTIVATION IN ANAPLASTIC THYROID CANCER IN MONOLAYER AND SPHEROID CELLS MODELS | PRESENTER: PALOMA RAMOS DE OLIVEIRA
13:15 - 13:20
1112399 - NIFUROXAZIDE ACTIVITY IN ANAPLASTIC THYROID CANCER: MODULATION OF CANCER STEM-LIKE CELL PROPERTIES AND THE INVOLVEMENT OF JAK/STAT3 PATHWAY | PRESENTER: GUSTAVO FELISOLA CASO
13:20 - 13:25
1112561 - SERUM MICRORNA ANALYSIS FACILITATES THE DECISION BETWEEN ACTIVE SURVEILLANCE AND IMMEDIATE SURGERY OF THYROID MICROCARCINOMA | PRESENTER:FERNANDA FARO
13:25 - 13:30
1112284 - STUDY ON THE ROLE AND MECHANISM OF MIOX IN REGULATING FERROPTOSIS IN PAPILLARY THYROID CARCINOMA | PRESENTER:SONGBO
13:30 - 13:35
1112306 - TARGETING PI3K/AKT/MTOR SIGNALING AND INHIBITION OF BCR/ABL TYROSINE KINASE AND GLUCOSE UPTAKE OVERCOMES RESISTANCE TO LENVATINIB IN THYROID CANCER | PRESENTER:SONAM KUMARI
13:35 - 13:40
1112572 - THE PHENOTYPE CORRELATED WITH NON CYSTEINE RET GERMLINE MUTATION IS CHARACTERIZED BY THE PRESENCE OF MEDULLARY THYROID CANCER ALONE | PRESENTER: Cristina Romei
13:40 - 13:45
1112601 - TRACING THE MOLECULAR ROUTE TO PROGRESSION IN DEFECTIVE MIRNA BIOGENESIS THYROID LESIONS | PRESENTER:BARBARA RIVERA POLO
13:45 - 13:50
1112265 - HETEROGENEITY OF MYELOID CELLS IN ANAPLASTIC THYROID CANCER: WHEN “NICHES” MATTER | PRESENTER: CORNUOT CLÉMENCE
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
13:00 - 14:00
SHORT ORAL COMMUNICATIONS ABSTRACTS

SHORT ORAL COMMUNICATIONS - Hyperthyroidism and Thyroid Eye Disease

13:00 - 13:05
1112436 - INFILTRATED MACROPHAGES CONTRIBUTE TO CARDIAC HYPERTROPHY ASSOCIATED WITH HYPERTHYROIDISM | PRESENTER: NATHALIA SENGER
13:05 - 13:10
1112560 - NEUTROPENIA IN CHILDREN WITH GRAVES‘ DISEASE TREATED WITH METHIMAZOLE: A CHINESE CHILDREN COHORT (3C) STUDY | PRESENTER: SHI TANG
13:10 - 13:15
1112530 - RESTING CARDIAC SYMPTOMS CAN PERSIST IN PATIENTS WITH GRAVES’ DISEASE TREATED TO STABLE EUTHYROIDISM | PRESENTER:ANOUK VAN HALL
13:15 - 13:20
1112364 - TIME-DEPENDENT CHANGES OF THE RISK OF ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTHYROIDISM RECEIVING RADIOACTIVE IODINE TREATMENT COMPARING TO ANTI-THYROID DRUG: A NATIONWIDE COHORT STUDY | PRESENTER:KYEONG JIN KIM
13:20 - 13:25
1112282 - RELATIONSHIP BETWEEN SERUM LEVELS OF SIROLIMUS (RAPAMYCIN) AND OUTCOME OF MODERATE-TO-SEVERE, ACTIVE GRAVES’ ORBITOPATHY | SIMONE COMI
13:25 - 13:30
1112533 - SPECIFIC INTRA-ORBITAL FAT AND MUSCLE LYMPHOCYTE INFILTRATES ARE ASSOCIATED WITH DIFFERENT CLINICAL MANIFESTATIONS OF THYROID EYE DISEASE | PRESENTER: ILARIA MULLER
13:30 - 13:35
1112239 - COMPARATIVE ANALYSIS OF ORBITAL TISSUE MICROENVIRONMENTS IN ACTIVE VERSUS INACTIVE THYROID EYE DISEASE: A SINGLE-CELL TRANSCRIPTOMICS APPROACH | PRESENTER: YUANPING HAI
13:35 - 13:40
1112238 - HIGH-THROUGHPUT PROTEOMICS COMBINED WITH IMMUNOHISTOCHEMISTRY OF ORBITAL CONNECTIVE TISSUE IN THYROID EYE DISEASE | PRESENTER:YUANPING HAI
13:40 - 13:45
1112503 - TWENTY-YEAR SECULAR TREND OF THYROTOXICOSIS AND THYROTOXIC PERIODIC PARALYSIS IN HONG KONG | PRESENTER: GLORIA HOI-YEE LI
13:45 - 13:50
1112363 - THERMOGRAPHIC ASSESSMENT OF THYROID EYE DISEASE IN RESPONSE TO STEROID THERAPY | PRESENTER: IVANA LOPES ROMERO KUSABARA
13:50 - 13:55
1112664 - MOLECULAR AND CLINICAL UPDATE IN THYROTOXIC PERIODIC PARALYSIS: A COMPREHENSIVE 30-YEAR STUDY OF A LARGE BRAZILIAN COHORT | PRESENTER:SUSAN CHOW LINDSEY
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
14:00 - 14:45
ETA PRIZE LECTURE GENERAL

ETA PRIZE LECTURE

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - CLINICAL THYROID CANCER 1

14:45 - 15:00
1112369 - CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF DIFFERENTIATED THYROID CANCER ACCORDING TO DISTANT METASTASIS STATUS | Presenter: Kamille Guidolin
15:00 - 15:15
1112243 - REAL WORLD RESULTS OF IMMUNE CHECKPOINT BLOCKERS IN ANAPLASTIC THYROID CARCINOMA PATIENTS: INSIGHT FROM THE COMEDIMS COMPASSIONATE PROGRAM AT GUSTAVE ROUSSY | Presenter: JULIEN HADOUX
15:15 - 15:30
1112439 - SURGERY FOR THYROID CANCER WITH OR WITHOUT AUTOFLUORESCENCE TO PREVENT HYPOPARATHYROIDISM – A RANDOMIZED, CONTROLLED TRIAL | Presenter:JACOB LILJA-FISCHER
15:30 - 15:45
1112557 - THE ROLE OF ADJUVANT VOLUMETRIC MODULATED ARC RADIOTHERAPY (VMAT) IN THE TREATMENT OF LOCALLY ADVANCED DIFFERENTIATED THYROID CANCER: A SINGLE INSTITUTION EXPERIENCE | Presenter: CHIARA MURA
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - CLINICAL THYROIDOLOGY 2

14:45 - 15:00
1113894 - Efficacy and Safety of Veligrotug (VRDN-001), a Full Antagonist Humanized Monoclonal Antibody to IGF-1 Receptor, in Chronic Thyroid Eye Disease (TED): THRIVE-2 Phase 3 Results at 15 Weeks | PRESENTER:PATRICE RODIEN
15:00 - 15:15
1114060 - Predicting Reoperation Outcomes in Papillary Thyroid Carcinoma Using Interpretable Machine Learning| PRESENTER:ZIMEI TANG
15:15 - 15:30
1114099 - TREATMENT OF CHRONIC HYPOPARATHYROIDISM POST THYROID CANCER SURGERY THROUGH INTER VIVO PARATHYROID TRANSPLANTATION | PRESENTER: LEONARDO KRUSCHEWSKY
15:30 - 15:45
1112357 - TRAB DYNAMICS AND SURGICAL OUTCOMES IN GRAVES‘ ORBITOPATHY: A RETROSPECTIVE ANALYSIS | PRESENTER: LAURA DELFINO
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - BASIC THYROIDOLOGY 1

14:45 - 15:00
1112250 - PATIENT-DERIVED HIPSC MODEL OF HUMAN BRAIN REVEAL MOLECULAR MECHANISMS OF CLINICAL CONSEQUENCES OF CEREBRAL SBP2 DEFICIENCY | PRESENTER: ULGU ARSLAN-VAN BERGEN
15:00 - 15:15
1112513 - PHENYLBUTYRATE INCREASES THYROXINE UPTAKE IN PRIMARY ASTROCYTES FROM MICE CARRYING A MCT8 MISSENSE MUTATION| PRESENTER: DOREEN BRAUN
15:15 - 15:30
1112197 - RHGH PARTIALLY IMPROVES CORTICAL AND HIPPOCAMPAL DEVELOPMENTAL IMPAIRMENTS IN TRΑ1 MUTANT MICE BY RESTORING THE GH/IGF-1 AXIS | PRESENTER:YANG LI
15:30 - 15:45
1112314 - THE RELEVANCE OF CO-REPRESSOR BINDING FOR THE RESISTANCE TO THYROID HORMONE ALPHA PHENOTYPE AS REVEALED BY A FAMILY CARRYING AN H175R VARIANT IN THE THYROID HORMONE RECEPTOR ALPHA | PRESENTER: MARCEL MEIMA
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - THYROID CANCER BASIC

14:45 - 15:00
1112461 - ANAPLASTIC THYROID CANCER CELL-SECRETED TGFΒ1 UPREGULATES THE EXPRESSION OF THE IMMUNE CHECKPOINT TIM3 IN HUMAN MONOCYTES | PRESENTER: AGUSTINA JAROSZEWSKI
15:00 - 15:15
1113747 - BISPHENOL-A EXPOSURE MAY BE RELATED TO THE GROWING INCIDENCE OF THYROID TUMORS AND THE OCCURRENCE OF MORE AGGRESSIVE CANCER TYPES | PRESENTER: ELISANGELA DE SOUZA TEIXEIRA
15:15 - 15:30
1113896 - CELL INTRINSIC IFN-I SIGNATURE CORRELATES WITH DEDIFFERENTIATION OF THYROID CANCER AND DETERMINES ITS IMMUNOLOGICAL FATE | PRESENTER: TIM BRANDENBURG
15:30 - 15:45
1112581 - UNRAVELING THYROID CANCER ORIGINS: A CUTTING-EDGE HUMAN THYROID ORGANOID MODEL | PRESENTER: EDUARDO ANDRÉS RIOS MORRIS
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - CLINICAL THYROIDOLOGY 1

14:45 - 15:00
1112344 - ASSOCIATION OF PERCHLORATE, THIOCYANATE, AND NITRATE WITH GESTATIONAL THYROID FUNCTION AND CHILD NEURODEVELOPMENT | PRESENTER: YINDI LIU
15:00 - 15:15
1112606 - CHARACTERIZATION AND IMPACT OF THE GESTATIONAL HYPOTHYROXINEMIC ENVIRONMENT ON MACROPHAGE POLARIZATION AND FUNCTION. | PRESENTER: EVELYN L. JARA FERNÁNDEZ
15:15 - 15:30
1112316 - THE FCRN INHIBITOR, BATOCLIMAB, RAPIDLY NORMALIZES THYROID FUNCTION IN GRAVES‘ HYPERTHYROIDISM: A PROOF-OF-CONCEPT STUDY | PRESENTER: GEORGE KAHALY
15:30 - 15:45
1112518 - THE IMPACT OF TRAB ON GUT MICROBIOTA AND NON-TARGET METABOLITES IN HUMAN AND MURINE MODEL WITH THYROID EYE DISEASE |PRESENTER: YANAN WANG
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
15:45 - 16:00
POSTER GENERAL

POSTER SESSION/BREAK IN THE EXHIBIT HALL

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
16:00 - 17:30
SYMPOSIUM THYROID CANCER

Treatment decisions in low risk thyroid cancer

16:00 - 16:25
Indications for Active surveillance
16:25 - 16:50
Less than total thyroidectomy: indications for hemithyroidectomy or RFA
16:50 - 17:15
Dynamic risk stratification, indications for completion thyroidectomy & RAI
17:15 - 17:30
Discussion
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
16:00 - 17:30
SYMPOSIUM REGULATION OF TH M&S

Developmental functions of thyroid hormone

16:00 - 16:25
Thyroid hormone and brain development
16:25 - 16:50
Thyroid hormone transporters and deiodinases in development
16:50 - 17:15
Thyroid hormone and neuronal differentiation in organoids
17:15 - 17:30
Discussion
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
16:00 - 16:50
MEET THE PROFESSOR THYROID DYSFUNCTION

Obesity following treatment for thyroid dysfunction

16:30 - 16:50
Discussion
Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
16:00 - 16:50
MEET THE PROFESSOR PEDIATRICS & GENETIC DISEASES

Management of Graves’s disease in children

16:30 - 16:50
Discussion
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
16:00 - 17:30
SYMPOSIUM THYROID NODULES

Emerging Trends in Thyroid Nodule Imaging

16:00 - 16:25
Performance of different US classification systems
16:25 - 16:50
Application of AI in thyroid nodule imaging
16:50 - 17:15
Contrast enhance imaging /elastography
17:15 - 17:30
Discussion
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
16:00 - 17:30
SYMPOSIUM THYROID & PREGNANCY

Update on Hyperthyroidism in Pregnancy

16:00 - 16:25
Thyroid storm in pregnancy
16:25 - 16:50
Iodide for the management of hyperthyroidism in pregnancy
16:50 - 17:15
Management in the post-partum
17:15 - 17:30
Discussion
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
18:00 - 20:00
GENERAL ASSEMBLY GENERAL ASSEMBLY

LATS General Assembly

Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
18:00 - 20:00
GENERAL ASSEMBLY GENERAL ASSEMBLY

AOTA General Assembly

Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
18:00 - 20:00
GENERAL ASSEMBLY GENERAL ASSEMBLY

ETA General Assembly

* Sponsored activities and lectures (such as Satellite Symposia) are conducted under the responsibility of the sponsoring company and follow its respective compliance rules. In addition to these rules, certain measures are also adopted, such as granting exclusive access to prescribers during the satellite symposia, in order to fully comply with ANVISA’s regulations, particularly those set forth in RDC nº. 96/2008. These restrictions will be disclosed in the scientific program.

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
07:00 - 08:25
EARLY RISER SYMPOSIA THYROID NODULES

Challenging clinical cases of Thyroid Nodules

07:00 - 08:25
Representative for ATA
07:00 - 08:25
Representative for ETA
07:00 - 08:25
Representative for AOTA
07:00 - 08:25
Representavive for LATS
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
08:30 - 09:00
PLENARY PLENARY SESSION

Opportunities and challenges of artificial intelligence in healthcare

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
09:00 - 09:30
PLENARY PLENARY SESSION

Modeling human thyroid development and diseases using stem cell-derived organoids

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
09:30 - 09:45
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
09:45 - 11:10
SYMPOSIUM THYROID CANCER

Novel therapeutic perspectives for advanced thyroid cancer

09:45 - 10:10
Advances in Medullary Thyroid Cancer
10:10 - 10:35
Redifferentiation therapy
10:35 - 11:00
Neoadjuvant therapy
11:00 - 11:10
Discussion
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
09:45 - 10:45
MEET THE PROFESSOR REGULATION OF TH M&S

Transcription and circadian control by thyroid hormone

09:45 - 10:10
Thyroid hormone and genomic regulation in amphibians
10:10 - 10:35
Thyroid hormone and circadian control
10:35 - 10:45
Discussion
Room 3 – Marcos S. Abalovich (LATS President 2011-2013; Argentina)
09:45 - 11:10
SYMPOSIUM GOITER, IODINE AND OTHER ENVIRONMENTAL FACTORS

Iodine, selenium and thyroid diseases

09:45 - 10:10
The structure, function, and mechanism of the Na+/I- symporter (NIS)
10:10 - 10:35
Iodine prophylaxis and its impact on thyroid diseases
10:35 - 11:00
Selenium and thyroid function: what is new
11:00 - 11:10
Discussion
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
09:45 - 10:35
MEET THE PROFESSOR AUTOIMMUNITY

IgG4 related thyroid disease

10:15 - 10:35
Discussion
Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
09:45 - 10:45
MEET THE PROFESSOR REGULATION OF TH M&S

Tissue responses to thyroid hormone

09:45 - 10:10
Patients with THRA and THRB receptor defects
10:10 - 10:35
Thyroid hormone and the immune system
10:35 - 10:45
Discussion
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
09:45 - 11:10
SYMPOSIUM PEDIATRICS & GENETIC DISEASES

Genetics in congenital Hypothyroidism

09:45 - 10:10
How genetics can modify the diagnosis and management of CH
10:10 - 10:35
Functional noncoding variants as new cause of CH
10:35 - 11:00
Dealing with variants of uncertain significance in the genetic diagnosis of congenital hypothyroidism
11:00 - 11:10
Discussion
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
09:45 - 10:35
MEET THE PROFESSOR THYROID NODULES

Controversies for and against routine serum calcitonin measurement and FNA washout in thyroid nodules

09:45 - 10:25
Screening YES/NO
10:25 - 10:35
Discussion
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
10:35 - 11:30
MEET THE PROFESSOR PEDIATRICS & GENETIC DISEASES

Thyroid nodule management in children

11:20 - 11:30
Discussion
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
11:15 - 12:00
MEET THE PROFESSOR THYROID CANCER

Outcomes in ATC: Is It Evolving into a Treatable Disease?

11:45 - 12:00
Discussion
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
11:15 - 12:00
MEET THE PROFESSOR THYROID & PREGNANCY

Hazards of endocrine disruptors in pregnancy

11:45 - 12:00
Discussion
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
11:15 - 12:00
MEET THE PROFESSOR GOITER, IODINE AND OTHER ENVIRONMENTAL FACTORS

Nuclear accidents and thyroid disease

11:15 - 11:45
The Effects of Radiation Exposure on the Thyroid Gland in Fukushima, Japan
11:45 - 12:00
Discussion
Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
12:00 - 13:00
ROUND TABLE GENERAL

International Round Table - Global challenges in thyroid health

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
13:00 - 14:00
SHORT ORAL COMMUNICATIONS ABSTRACTS

SHORT ORAL COMMUNICATIONS - Thyroid Nodule and Cancer

13:00 - 13:05
1112394 - PROGNOSTIC VALUE OF RET STATUS IN PATIENTS WITH UNRESECTABLE MEDULLARY THYROID CANCER TREATED BY VANDETANIB: THE PRONOMED STUDY | Presenter: NOÉMIE SIMON-TILLAUX
13:05 - 13:10
1112624 - MOLECULAR CHARACTERIZATION OF A LARGE SERIES OF SUBCENTIMETRIC PAPILLARY THYROID CARCINOMAS | Presenter: ELISABETE OLIVEIRA TEIXEIRA
13:10 - 13:15
1114103 - The Genomic Landscape of 250,000+ Thyroid Nodules Undergoing Exome-enriched RNA Sequencing | Presenter: Sarah Hamidi
13:15 - 13:20
1112612 - SAFETY AND EFFICACY OF SELPERCATINIB TREATMENT IN ADVANCED MEDULLARY THYROID CANCER PATIENTS: A REAL-LIFE STUDY | Presenter:ANTONIO MATRONE
13:20 - 13:25
1112424 - ULTRASOUND-GUIDED CRYOABLATION, LASER OR RADIOFREQUENCY ABLATION OF CERVICAL METASTASES FROM THYROID CARCINOMA: A PROSPECTIVE CLINICAL TRIAL | Presenter:RICARDO MIGUEL COSTA DE FREITAS
13:25 - 13:30
1112312 - VALIDATION OF THE INTERNATIONAL MEDULLARY THYROID CANCER GRADING SYSTEM AND IDENTIFICATION OF EZH2 AS A PROGNOSTIC AND POTENTIAL THERAPEUTIC MARKER IN MEDULLARY THYROID CANCER PATIENTS | Presenter:ELINE CESILIE JAGER
13:30 - 13:35
1112193 - VASCULAR INVASION AS A PREDICTOR OF DISTANT RECURRENCE IN FOLLICULAR CARCINOMAS: ARE THE DEFINITIONS OF ‘WIDELY INVASIVE FOLLICULAR CARCINOMA‘ AND ‘ENCAPSULATED ANGIOINVASIVE FOLLICULAR CARCINOMA‘ APPROPRIATE? | Presenter: YASHURO ITO
13:35 - 13:40
1114005 - Lenvatinib treatment as a neoadjuvant option in locally advanced thyroid cancer | Presenter: ALEJANDRO ROMAN GONZALEZ
13:40 - 13:45
1113739 - Unstimulated Postoperative Thyroglobulin Is Highly Accurate In Predicting Treatment Response In High-Risk Differentiated Thyroid Cancer Patients - A Retrospective Cohort Study | Presenter: JULIA ISABEL RICHTER CICOGNA
13:45 - 13:50
1112619 - ANAPLASTIC THYROID CANCER UNDERGOES GENOMIC AND PHENOTYPIC PLASTICITY IN RESPONSE TO BRAF INHIBITOR TREATMENT | Presenter: XIAO ZHAO
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
13:00 - 14:00
SHORT ORAL COMMUNICATIONS ABSTRACTS

SHORT ORAL COMMUNICATIONS - Thyroid Cell Biology, Thyroid Hormone Action and Metabolism

13:00 - 13:05
1112526 - THE NLRP3/TLR2/NFΚB PATHWAY IS INVOLVED IN THE OCCURRENCE OF MISCARRIAGE IN AIT PATIENTS
13:05 - 13:10
1112372 - FUNCTIONAL ANALYSIS OF SLC5A5 GENE VARIANTS ASSOCIATED WITH CONGENITAL HYPOTHYROIDISM | PRESENTER:GERARDO HERNÁN CARRO
13:10 - 13:15
1112321 - FUNCTIONAL TESTING OF POTENTIAL NOVEL THYROID HORMONE TRANSPORTERS INFORMED BY A LARGE SCALE THYROID FUNCTION GENOME-WIDE ASSOCIATION STUDY | MATTHIJS FREUND
13:15 - 13:20
1113717 - GESTATIONAL HYPOTHYROXINEMIA DAMAGES THE INTESTINAL INTEGRITY IN THE ILEUM OF THE ADULT OFFSPRING | MARIA JOSE MENDOZA LEON
13:20 - 13:25
1112598 - TRIIODOTHYRONINE MODULATES DENDRITIC CELL-DERIVED EXTRACELLULAR VESICLES AND THEIR ROLE IN IMMUNE RESPONSE REGULATION | MARIANA PIRES CAVALCANTI TEIXEIRA
13:25 - 13:30
1112374 - PATHOGENIC VARIANTS IN CONSERVED RESIDUES OF SLC5A FAMILY MEMBERS REVEALED KEY RESIDUES FOR NIS FUNCTION | GERARDO HERNÁN CARRO
13:30 - 13:35
1112276 - NEW INSIGHTS INTO THYROID HORMONE METABOLISM AND AMMONIA DETOXIFICATION IN MASLD USING N-ACETYLCYSTEINE (NAC) AND L-ORNITHINE L-ASPARTATE (LOLA) | SIMONE WAJNER
13:35 - 13:40
1112274 - TYPE 3 DEIODINASE IS ACTIVATED IN THE BRAIN OF AN ANIMAL MODEL OF METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE (MASLD).| SIMONE WAJNER
13:40 - 13:45
1114179 - Chronic iodine excess induced TSH elevation by inactivating Type 2 deiodinase via ROS/AKT-mTOR-GSK3β/NRF2 signaling pathway | XIAOTONG GAO
13:45 - 13:50
1112292 - IFNΑ TRIGGERS AUTOIMMUNE THYROIDITIS BY RESHAPING THYROGLOBULIN IMMUNOGENIC PEPTIDE REPERTOIRE| MIHAELA STEFAN LIFSHITZ
13:50 - 13:55
1112184 - INTEGRATED TRANSCRIPTOMIC AND EPIGENETIC PROFILING OF THYROCYTES IN AUTOIMMUNE THYROIDITIS VIA SINGLE CELL RNA-SEQ, BULK RNA-SEQ AND DNA METHYLATION PROFILING | TINGTING LIU
Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
13:00 - 14:00
SHORT ORAL COMMUNICATIONS ABSTRACTS

SHORT ORAL COMMUNICATIONS - Endocrine Disruptors and Thyroid Disfunctions (Basic)

13:05 - 13:10
1112254 - HISTONE ACETYLTRANSFERASE LOSS-OF-FUNCTION PROMOTES THYROID CANCER PROGRESSION IN VIVO AND SENSITIZES HUMAN THYROID CANCER CELLS TO HIGHLY SPECIFIC PROTEIN DEGRADERS
13:10 - 13:15
1112515 - BISPHENOL A, PERCHLORATE, AND NITRATE MIXTURE DISRUPTS CELL DIFFERENTIATION AND ALTERS EPIGENETIC MECHANISMS AND SIGNALING PATHWAYS IN THYROCYTES | PRESENTER: EVELYN FRANCINY CARDOSO TAVARES
13:15 - 13:20
1112589 - FOXE1 DOMAINS AT THE CROSSROAD BETWEEN EVOLUTION AND THYROID FUNCTIONALITY| PRESENTER:ELISA STELLARIA GRASSI
13:20 - 13:25
1112446 - HYPOTHYROIDISM PROMOTES A SARCOPENIA-LIKE PHENOTYPE IN YOUNG BUT NOT IN AGED MICE | PRESENTER:THAMIRES SIQUEIRA DE OLIVEIRA
13:25 - 13:30
1112233 - DEVELOPING A TESTING BATTERY FOR DEVELOPMENTAL NEUROTOXICITY MEDIATED VIA DISRUPTED THYROID HORMONE HOMEOSTASIS | PRESENTER:NATHALIE DIERICHS
13:30 - 13:35
1112514 - MATERNAL EXPOSURE TO TRICLOSAN DURING THE INTRAUTERINE PERIOD DISRUPTS THYROID DEVELOPMENT AND FUNCTION IN THE OFFSPRING ANIMALS | PRESENTER:GUILHERME HENRIQUE
13:35 - 13:40
1112511 - POLYCHLORINATED BIPHENYLS DISRUPT GENE EXPRESSION, NIS FUNCTION, AND KEY SIGNALING PATHWAYS IN HUMAN THYROID CELLS | PRESENTER:VINICIUS GONÇALVES RODRIGUES
13:40 - 13:45
1112360 - TRANSCRIPTOMIC PROFILING OF THYROID CELLS EXPOSED TO ROUNDUP® ORIGINAL DI REVEALS DOSE-DEPENDENT EFFECTS: IMPLICATIONS FOR SAFETY STANDARDS | PRESENTER:IZABELA FERNANDA DAL BO CRUZ
13:45 - 13:50
1113992 - DEHAL1 modulates oxidative stress induced by endogenous and anthropogenic oxidants. | PRESENTER: José C. Moreno
13:50 - 13:55
1112208 - THE ROLE OF THYROID HORMONE IN SUSCEPTIBILITY TO TYPE 2 DIABETES IN OFFSPRING: REGULATORY MECHANISMS OF THE PLACENTAL GENOMIC IMPRINT AT THE DLK1-DIO3 LOCUS IN WOMEN WITH HYPOTHYROIDISM. | PRESENTER: MARIA BEATRIZ BRAVIN
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
13:00 - 14:00
SHORT ORAL COMMUNICATIONS ABSTRACTS

SHORT ORAL COMMUNICATIONS - Thyroid Disfunctions

13:00 - 13:05
1112209 - CARDIAC COMPLICATIONS IN PATIENTS WITH RESISTANCE TO THYROID HORMONE DUE TO THYROID HORMONE RECEPTOR BETA GENE MUTATIONS (RTHΒ) | PRESENTER: NATSUKO WATANABE
13:05 - 13:10
1112223 - THE IMPACT OF HEALTH LITERACY ON HYPOTHYROIDISM MANAGEMENT IN PATIENTS UNDERGOING LEVOTHYROXINE THERAPY | PRESENTER:JESSYKA
13:10 - 13:15
1112656 -IODINE, HEAVY METALS, AND THYROID FUNCTION IN PREGNANCY: A CROSS-SECTIONAL STUDY IN BOTUCATU, BRAZIL.| PRESENTER: ADRIANO FRANCISCO DE MARCHI JUNIOR
13:15 - 13:20
1112508 - MILD IODINE DEFICIENCY DURING THE INTRAUTERINE PERIOD DISRUPTS THE PITUITARY-THYROID AXIS OF THE OFFSPRING DURING ADULT LIFE | PRESENTER: THACILA DE OLIVEIRA MARQUES
13:20 - 13:25
1112574 - MATERNAL HYPOTHYROXINEMIA IN EARLY PREGNANCY AND OFFSPRING NEURODEVELOPMENT: A PROSPECTIVE INTERVENTION STUDY | PRESENTER: YUTONG HAN
13:25 - 13:30
1112225 - NEWBORN SCREENING FOR CONGENITAL HYPOTHYROIDISM: WORLDWIDE COVERAGE 50 YEARS AFTER ITS START | PRESENTER: CHRISTIAAN MOOIJ
13:30 - 13:35
1112611 - IODINE STATUS QUESTIONNAIRE ASSESSMENT DURING PREGNANCY: A PILOT STUDY. | PRESENTER: MARIA IZABEL CHIAMOLERA
13:35 - 13:40
1112323 - TREATMENT PATTERNS AMONG METHIMAZOLE-TREATED PATIENTS WITH GRAVES’ DISEASE | PRESENTER: LESLEY-ANN MILLER-WILSON
13:40 - 13:45
1112418 - THYROID AUTOIMMUNITY AND PREGNANCY: IMPLICATIONS FOR MATERNAL AND FETAL HEALTH OUTCOMES | CAMILA BERGER DE OLIVEIRA CUNHA
13:45 - 13:50
1112587 - CLINICAL IMPLICATIONS FOR OBESITY MANAGEMENT: BARIATRIC SURGERY-INDUCED CHANGES IN TSH AND ITS CORRELATION WITH THE NEW MODEL OF OBESITY CLASSIFICATION PROPOSAL BY SBEM/ABESO, A CROSS SECTIONAL STUDY. | PRESENTER:ADRIANO FRANCISCO DE MARCHI JUN
13:50 - 13:55
1114292 - Subclinical hypothyroidism as a risk for coronary artery bypass grafting | PRESENTER: GIOVANNA APARECIDA BALARINI LIMA
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
14:00 - 14:45
ATA PRIZE LECTURE GENERAL

ATA PRIZE LECTURE

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - CLINICAL THYROID CANCER 2

14:45 - 15:00
1112621- A TUMOR-CELL SPECIFIC GENE SIGNATURE DERIVED FROM SINGLE-CELL SEQUENCING IS PROGNOSTIC ACROSS INDEPENDENT COHORTS OF PAPILLARY THYROID CARCINOMA PATIENTS | PRESENTER: JENNIFER RUI WANG
15:00 - 15:15
1112553 - GENETIC ANCESTRY OF RET MUTATIONS AT CODON 804 REVEALS A BOTTLENECK EFFECT AMONG BRAZILIANS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 | PRESENTER: VICTOR ALEXANDRE DOS SANTOS VALSECCHI
15:15 - 15:30
1112616 - MOLECULAR PROFILE OF ADVANCED RADIOIODINE-REFRACTORY THYROID CANCER AND RESPONSE TO LENVATINIB TREATMENT | PRESENTER: ELISA MINALDI
15:30 - 15:45
1112244 - THE SIGNIFICANCE OF APOPTOSIS DYSREGULATION IN CLINICAL MANAGEMENT OF PAPILLARY THYROID CANCER: IDENTIFICATION OF NOVEL THERAPEUTIC TARGETS | PRESENTER: ADAMSKA AGNIESZKA
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - PEDIATRIC THYROIDOLOGY

14:45 - 15:00
1114004 - TOCILIZUMAB VS METHYLPREDNISOLONE IN MODERATE-SEVERE GRAVES' ORBITOPATHY: RESULTS OF AN ITALIAN MULTICENTER CLINICAL TRIAL | PRESENTER: MARIO SALVI
15:00 - 15:15
1112453 - DISEASE PRESENTANTION AND DISTINCT GENETIC PROFILES ARE RELATED TO GENDER AND PUBERTY COMPLETION IN PEDIATRIC DIFFERENTIATED THYROID CARCINOMA | PRESENTER: Paulo Alonso Garcia Alves
15:15 - 15:30
1112255 - NEWBORNS THYROGLOBULIN IS A MORE SENSITIVE BIOMARKER FOR MONITORING IODINE STATUS THAN NEONATAL TSH | PRESENTER: CAMILO FUENTES PEÑA
Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - BASIC THYROIDOLOGY 2

14:45 - 15:00
1112486 - EVALUATING INSULIN‘S IMPACT ON THYROID DEVELOPMENT USING HUMAN THYROID ORGANOIDS | PRESENTER: SABINE COSTAGLIOLA
15:00 - 15:15
1112269 - INDUCTION OF TYPE 2 AND 3 DEIODINASES IN MUSCLE STEM CELLS OF CRITICALLY ILL PATIENTS: UNVEILING THE IMPLICATIONS FOR HYPERGLYCEMIA AND NON-THYROIDAL ILLNESS SYNDROME | PRESENTER: Thaliane Carvalho Oliveira
15:15 - 15:30
1112499 - UNREVEALING THE EPIGENETIC MECHANISMS TRIGGERED BY TSH IN THE STIMULATION OF THYROID DIFFERENTIATION MARKERS GENE EXPRESSION| PRESENTER:VINICIUS GONÇALVES RODRIGUES
15:30 - 15:45
1113824 - Identification and Characterization of GC-Cells: A Novel Population of Benign Epithelial Cells Involved in Lymph Node Metastasis of Papillary Thyroid Carcinoma | PRESENTER: YEFENG CAI
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - THYROID NODULES

14:45 - 15:00
1112222 - AN UNBIASED, AI-DRIVEN, QUANTITATIVE SURVEY OF HISTOLOGY IN HUMAN ASYMPTOMATIC THYROIDS REVEALS THE EXTENT OF NATURAL MORPHOLOGICAL VARIATION AND HISTOLOGICAL QTLS | PRESENTER: VINCENT DETOURS
15:00 - 15:15
1112207 - CORE-NEEDLE BIOPSY IS A SAFE AND VALUABLE OPTION. FIRST 532 PROCEDURES IN ROMANIA | PRESENTER: EMIN MAMMADOV
15:15 - 15:30
1112465 - RESULTS OF A SERIES OF 167 CASES OF MICROWAVE ABLATION FOR BENIGN THYROID NODULES | PRESENTER: CARLOS NEUTZLING LEHN
15:30 - 15:45
1114232 - Prospective results for active surveillance of RAS-positive indeterminate thyroid nodules with Bethesda III and IV cytologies | PRESENTER: MARKUS ESZLINGER
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - CLINICAL THYROIDOLOGY 3

14:45 - 15:00
1112368 - ASSOCIATION BETWEEN SUBCLINICAL HYPOTHYROIDISM AND CHRONIC KIDNEY DISEASE INCIDENCE: INSIGHTS FROM ELSA-BRASIL | PRESENTER: DANIELLA ARAUJO MUNIZ
15:00 - 15:15
1112232 - DIFFERENT INHIBITING MECHANISMS OF AN ANTI-IGF-1R SMALL MOLECULE VERSUS AN ANTI-IGF-1R MONOCLONAL ANTIBODY | PRESENTER: GEORGE KAHALY
15:15 - 15:30
1112417 -IMPACT OF ENDOCRINE DISRUPTORS ON THYROID FUNCTION AND REPRODUCTIVE HEALTH: INSIGHTS INTO THE HYPOTHALAMIC-PITUITARY-THYROID AXIS | PRESENTER: CAMILA BERGER DE OLIVEIRA CUNHA
15:30 - 15:45
1112313 - MULTIPLE ASSAY INTERFERENCES LEADING TO THE DIAGNOSIS OF LYMPHOPROLIFERATIVE DISORDERS | PRESENTER: IRENE CAMPI
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
15:45 - 16:00
POSTER GENERAL

POSTER SESSION/BREAK IN THE EXHIBIT HALL

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
16:00 - 17:30
SYMPOSIUM THYROID NODULES

Alternative approaches to indeterminate nodule management

16:00 - 16:25
Active surveillance for indeterminate thyroid nodules
16:25 - 16:50
Minimally invasive management of thyroid nodules
16:50 - 17:15
Endoscopic surgery
17:15 - 17:30
Discussion
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
16:00 - 17:30
SYMPOSIUM GOITER, IODINE AND OTHER ENVIRONMENTAL FACTORS

Impact of Radiological and Chemical Exposure on Thyroid Health

16:00 - 16:25
Human radiation exposure and thyroid genetic alterations
16:25 - 16:50
Chemical disruptors and neonatal screening
16:50 - 17:15
Endocrine Disruptors in Thyroid Disease
17:15 - 17:30
Discussion
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
16:00 - 16:50
MEET THE PROFESSOR REGULATION OF TH M&S

Current topics in Nonthyroidal Illness Syndrome

16:00 - 16:30
Understanding the mechanisms behind the disorders
16:30 - 16:50
Discussion
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
16:00 - 17:30
SYMPOSIUM THYROID CANCER

Novel Advances in Thyroid Cancer Research

16:00 - 16:25
TERT promoter mutations as a driver of tumor aggression
16:25 - 16:50
Tumor Microenvironment in thyroid cancer differentiation
16:50 - 17:15
The Role of Deiodinases in Thyroid Tumorigenesis
17:15 - 17:30
Discussion
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
16:00 - 17:30
SYMPOSIUM THYROID DYSFUNCTION

End-Organ Effects of Hyperthyroidism

16:00 - 16:25
Heart and vascular risk
16:25 - 16:50
Bones and fracture risk
16:50 - 17:15
Mental health and cognition
17:15 - 17:30
Discussion

* Sponsored activities and lectures (such as Satellite Symposia) are conducted under the responsibility of the sponsoring company and follow its respective compliance rules. In addition to these rules, certain measures are also adopted, such as granting exclusive access to prescribers during the satellite symposia, in order to fully comply with ANVISA’s regulations, particularly those set forth in RDC nº. 96/2008. These restrictions will be disclosed in the scientific program.

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
08:00 - 09:30
EARLY RISER SYMPOSIA THYROID & PREGNANCY

Masterclass: Impact of thyroid disease & pregnancy (Reasons not to panic)

08:00 - 08:20
Maternal hypothyroxinaemia: treat or observe
08:20 - 08:40
Autoimmunity with assisted reproduction
08:40 - 09:00
Uncontrolled Graves' disease
09:00 - 09:20
Treatment of MCT8 Deficiency during Pregnancy
09:20 - 09:30
Discussion
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
09:30 - 10:15
AOTA PRIZE LECTURE GENERAL

AOTA PRIZE LECTURE

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
10:15 - 10:30
POSTER Break

POSTER SESSION/BREAK IN THE EXHIBIT HALL

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
10:30 - 12:00
SYMPOSIUM THYROID NODULES

Indeterminate Nodules: Molecular and Genomic Strategies Across Different Regions

10:30 - 10:50
North America/Canada
10:50 - 11:10
Europe
11:10 - 11:30
Asia
11:30 - 11:50
Latin America
11:50 - 12:00
Discussion
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
10:30 - 12:00
DEBATE AUTOIMMUNITY

Early definitive treatment of Graves' hyperthyroidism is the gold standard

10:30 - 10:50
For the proposal
10:50 - 11:10
Against the proposal
11:10 - 12:00
Discussion
Room 3 – Marcos S. Abalovich (LATS President 2011-2013; Argentina)
10:30 - 12:00
SYMPOSIUM REGULATION OF TH M&S

Thyroid Hormone and the nervous system

10:30 - 10:55
Thyroid hormone transport and the CNS
10:55 - 11:20
Deiodinases and brain function
11:20 - 11:45
Thyroid hormone and neuronal differentiation
11:45 - 12:00
Discussion
Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
10:30 - 12:00
SYMPOSIUM AUTOIMMUNITY

Environmental Factors and Their Impact on Thyroid Autoimmunity

10:30 - 10:55
Selenium and vitamin D in Hashimoto thyroiditis
10:55 - 11:20
Microbiome in thyroid autoimmunity
11:20 - 11:45
Stress and lifestyle in pathogenesis of AITD
11:45 - 12:00
Discussion
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
10:30 - 12:00
SYMPOSIUM THYROID CANCER

Genomics of Thyroid Cancer

10:30 - 10:55
Oncocytic thyroid cancer: new lessons from an old tumor
10:55 - 11:20
Clinical utility of micro RNA expression
11:20 - 11:45
Mechanisms of development of drug resistance to targeted therapies
11:45 - 12:00
Discussion
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
10:30 - 12:00
SYMPOSIUM THYROID DYSFUNCTION

What's New in Hypothyroidism? Recent Advances and Insights

10:30 - 10:55
Metabolic and lipid effects
10:55 - 11:20
Thyroid hormone agonists in metabolic liver disease
11:20 - 11:45
Management of refractory hypothyroidism
11:45 - 12:00
Discussion
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 3 – Marcos S. Abalovich (LATS President 2011-2013; Argentina)
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
13:00 - 14:00
DEBATE THYROID CANCER

Use of molecular testing for initial treatment decisions in low and intermediate risk thyroid cancers

13:00 - 13:20
YES
13:20 - 13:50
NO
13:50 - 14:00
Discussion
Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
13:00 - 13:50
MEET THE PROFESSOR THYROID DYSFUNCTION

The Dilemma of Subclinical Hyperthyroidism: Treat or Observe?

13:00 - 13:30
Subclinical Hyperthyroidism: Treat or observe?
13:30 - 13:50
Discussion
Room 3 – Marcos S. Abalovich (LATS President 2011-2013; Argentina)
13:00 - 13:50
MEET THE PROFESSOR THYROID DYSFUNCTION

Thyroid dysfunction with Immune Checkpoint inhibitors

13:00 - 13:30
Thyroid dysfunction with Immune Checkpoint inhibitors
13:30 - 13:50
Discussion
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
13:00 - 14:00
MEET THE PROFESSOR REGULATION OF TH M&S

Hypothalamic-pituitary-thyroid axis

13:00 - 13:20
Update on T4 monotherapy and the HPT axis
13:20 - 13:40
Hypothalamic control of the thyroid axis
13:40 - 14:00
Discussion
Room 5 – Gustavo Pineda (LATS President 1995–97; Chile)
13:00 - 13:50
MEET THE PROFESSOR THYROID CANCER

Approaches to Managing Toxicity in TKI Treatment

13:30 - 13:50
Discussion
Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
13:00 - 14:30
SYMPOSIUM THYROID & PREGNANCY

Fetal Risks Associated with Thyroid Disorders

13:00 - 13:25
Long-term impact of in utero thyroid hormone exposure
13:25 - 13:50
Hazards of hyperthyroidism and antithyroid drugs
13:50 - 14:15
TRAb and fetal outcome
14:15 - 14:30
Discussion
Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
13:00 - 13:50
MEET THE PROFESSOR GENERAL

Alternative Management of Malignant thyroid disease including minimal invasive treatments

13:30 - 13:50
Discussion
Room 1 - Geraldo A. Medeiros Neto (LATS President 1974–78; Brazil)
14:30 - 15:00
CLOSING EVENT CLOSURE

17th International Thyroid Congress - Concludes

* Sponsored activities and lectures (such as Satellite Symposia) are conducted under the responsibility of the sponsoring company and follow its respective compliance rules. In addition to these rules, certain measures are also adopted, such as granting exclusive access to prescribers during the satellite symposia, in order to fully comply with ANVISA’s regulations, particularly those set forth in RDC nº. 96/2008. These restrictions will be disclosed in the scientific program.

Room 2 – Eduardo Gaitán (LATS President 1982–85; Colombia)
12:00 - 13:00
SATELLITE SYMPOSIUM ABBOTT

Common Challenges in Clinical Thyroidology (Restricted to prescribers)

12:00 - 12:20
Preview of the 2025 American Thyroid Association (ATA) nodules guidelines and how to apply to fine needle aspiration (FNA) decision making
12:20 - 12:40
Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin America
12:40 - 13:00
Round table/ Q&A
Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
12:00 - 13:00
SATELLITE SYMPOSIUM LILLY

Patient Journey: how molecular tests are changing Thyroid Cancer diagnosis and treatment in Brazil (Restricted to prescribers)

Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
12:00 - 13:00
SATELLITE SYMPOSIUM AMGEN

The Role of Tissue Remodeling in Thyroid Eye Disease Treatment​: Integrating Multidisciplinary Insights and Innovations (Restricted to prescribers)

Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
12:00 - 13:00
SATELLITE SYMPOSIUM MERCK

Update in Hypothyroidism (Restricted to prescribers)

12:00 - 12:20
Subclinical Hypothyroidism
12:20 - 12:40
Cardiovascular involvement in overt hypothyroidism
12:40 - 13:00
Combined T3 +LT4 therapy vs. LT4 monotherapy in patients with hypothyroidism

* Sponsored activities and lectures (such as Satellite Symposia) are conducted under the responsibility of the sponsoring company and follow its respective compliance rules. In addition to these rules, certain measures are also adopted, such as granting exclusive access to prescribers during the satellite symposia, in order to fully comply with ANVISA’s regulations, particularly those set forth in RDC nº. 96/2008. These restrictions will be disclosed in the scientific program.

Room 6 – Hugo Niepomniszcze (LATS President 1997–99; Argentina)
12:00 - 13:00
SATELLITE SYMPOSIUM IMMUNOVANT

Current Management and Novel Approach for Graves' Hyperthyroidism (Restricted to prescribers)

Room 7 – Aldo H. Coleoni (LATS President 2001-2003; Argentina)
12:00 - 13:00
SATELLITE SYMPOSIUM MERCK

Hypothyroidism as a Chronic Condition – A Lifelong Patient Journey. Case Study Discussion (Restricted to prescribers)

* Sponsored activities and lectures (such as Satellite Symposia) are conducted under the responsibility of the sponsoring company and follow its respective compliance rules. In addition to these rules, certain measures are also adopted, such as granting exclusive access to prescribers during the satellite symposia, in order to fully comply with ANVISA’s regulations, particularly those set forth in RDC nº. 96/2008. These restrictions will be disclosed in the scientific program.

Room 4 – Jorge Maisterrena (LATS President 1986–90; Mexico)
12:00 - 13:00
SATELLITE SYMPOSIUM QUIDEL ORTHO

TSH Receptor Antibody Bioassay
Methodological progress
Clinical application

Meeting Room – Doris Rosenthal (LATS President 2003–2005; Brazil)
09:00 - 10:00
MEETING -

Presidents and secretaries of the ETA, ATA, AOTA and LATS

Meeting Room – Doris Rosenthal (LATS President 2003–2005; Brazil)
17:30 - 19:30
MEETING -

IGN Meeting

Meeting Room – Doris Rosenthal (LATS President 2003–2005; Brazil)
10:00 - 11:00
MEETING -

Merck

Meeting Room – Doris Rosenthal (LATS President 2003–2005; Brazil)
13:00 - 15:00
MEETING -

AOTA Council Meeting

Meeting Room – Doris Rosenthal (LATS President 2003–2005; Brazil)
12:00 - 13:00
MEETING -

Thyroid cancer consortium